Work

Figure S13 from Resistance to the KRASG12D Inhibitor MRTX1133 Is Associated with Increased Sensitivity to BET Inhibition

Year: 2026

Type: other

Abstract: The combination of MRTX1133 and JQ1 reduces FOSL1 and BCL2 expression in metastatic lesions in the 2138K tumor model

DOI: 10.1158/1535-7163.32530598

Authors: Daniel R. Principe, Jeffrey H. Becker, Anastasia E. Metropulos, Alejandra M. Marinelarena, Thao D. Pham, Alexandre F. Aissa, Hidayatullah G. Munshi

Topic: Protein Degradation and Inhibitors

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W7163050097

Cites:

Cited by:

Related to: